Risk minimisation material: Xalkori (crizotinib) patient information booklet

This booklet covers the indication for use (ALK+ve and ROS1+ve non-small-cell lung cancer), how treatment works, the potential adverse effects of treatment (e.g. liver failure, lung inflammation), and what patients should do if they feel they are experiencing them.

Source:

Pfizer